献血者性别及既往妊娠与红细胞输注受血者死亡率的相关性
该研究分析了3个回顾性队列(KPNC、REDS-III、SCANDAT)的输血受血者数据,评估女性献血者、既往妊娠献血者及性别不一致献血者的红细胞输注与住院死亡率的关系。在调整红细胞输注单位数后,3个队列均未发现上述献血者暴露与住院死亡率存在统计学显著关联。
要点
- 在KPNC、REDS-III和SCANDAT三个队列中,女性献血者、既往妊娠献血者及性别不一致献血者的红细胞输注与住院死亡率均无统计学显著关联。
- 每输注1单位女性献血者红细胞,住院死亡率风险比在KPNC队列为0.99(95%CI 0.96-1.03),REDS-III队列为1.00(95%CI 0.99-1.01),SCANDAT队列为1.00(95%CI 0.99-1.00)。
核心结论
- 在红细胞输注受血者中,来自女性、既往妊娠或性别不一致献血者的输血与死亡率增加无显著关联。
研究设计与样本
- 研究分析了3个回顾性队列的输血受血者数据:Kaiser Permanente Northern California(KPNC)数据库和Recipient Epidemiology and Donor Evaluation Study-III(REDS-III)数据库的数据时间为2013年1月至2016年12月,Scandinavian Donations and Transfusions(SCANDAT)数据库的数据时间为2003年1月至2012年12月。
- KPNC和REDS-III队列的最终随访日期为2016年12月31日,SCANDAT队列的最终随访日期为2012年12月31日。
- 采用分层Cox回归模型估计献血者暴露组与死亡风险之间的关联,并调整红细胞输注单位数。
主要发现
- 研究人群包括KPNC队列34662例患者(平均年龄69岁;18652例[54%]为女性),REDS-III队列93724例患者(平均年龄61岁;48348例[52%]为女性),SCANDAT队列918996例患者(平均年龄72岁;522239例[57%]为女性)。
- 每例患者红细胞输注中位数在KPNC队列为3单位,REDS-III队列为2单位,SCANDAT队列为3单位。
- 来自既往妊娠或经产献血者的输血百分比在KPNC队列为9%,REDS-III队列为18%,SCANDAT队列为25%。
- KPNC队列住院死亡3217例,REDS-III队列住院死亡8519例,SCANDAT队列住院死亡198537例。
- 每输注1单位女性献血者红细胞,住院死亡率风险比在KPNC队列为0.99(95%CI 0.96-1.03),REDS-III队列为1.00(95%CI 0.99-1.01),SCANDAT队列为1.00(95%CI 0.99-1.00);每输注1单位既往妊娠或经产女性献血者红细胞,风险比在KPNC队列为1.00(95%CI 1.00-1.01),REDS-III队列为1.01(95%CI 0.98-1.03),SCANDAT队列为1.00(95%CI 1.00-1.01);每输注1单位性别不一致输血,风险比在KPNC队列为1.02(95%CI 0.99-1.05),REDS-III队列为0.99(95%CI 0.98-1.00),SCANDAT队列为1.00(95%CI 0.99-1.00)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Evidence regarding associations of blood donor sex with mortality among red blood cell transfusion recipients is conflicting. OBJECTIVE: To study associations of donor sex and prior pregnancy with mortality of transfusion recipients. DESIGN, SETTING, AND PARTICIPANTS: Data from 3 retrospective cohorts of transfusion recipients (the Kaiser Permanente Northern California [KPNC] and Recipient Epidemiology and Donor Evaluation Study-III [REDS-III] databases of data from January 2013 to December 2016 and the Scandinavian Donations and Transfusions [SCANDAT] database with data from January 2003 to December 2012) were analyzed. Final dates of follow-up were December 31, 2016, for the KPNC and REDS-III cohorts and December 31, 2012, for the SCANDAT cohort. Stratified Cox regression models were used to estimate associations between donor exposure groups with risk of mortality, adjusting for the number of red blood cell unit transfusions. EXPOSURES: The number of transfused red blood cell units from female donors, previously pregnant donors, and sex-discordant donors (male donor and female recipient or female donor and male recipient). MAIN OUTCOMES AND MEASURES: In-hospital mortality. RESULTS: The study population included 34 662 patients (mean age, 69 years; 18 652 [54%] women) from the KPNC cohort, 93 724 patients (mean age, 61 years; 48 348 [52%] women) from the REDS-III cohort, and 918 996 patients (mean age, 72 years; 522 239 [57%] women) from the SCANDAT cohort. The median number of red blood cell transfusions per patient was 3 in the KPNC cohort, 2 in the REDS-III cohort, and 3 in the SCANDAT cohort. The percentage of transfusions from previously pregnant or parous donors was 9% in the KPNC cohort, 18% in the REDS-III cohort, and 25% in the SCANDAT cohort. The percentage of transfusions in the 3 cohorts from female donors ranged from 39% to 43%, from previously pregnant or parous donors ranged from 9% to 25%, and from sex-discordant donors ranged from 44% to 50%. There were 3217 in-hospital deaths in the KPNC cohort, 8519 in the REDS-III cohort, and 198 537 in the SCANDAT cohort. There were no statistically significant associations between any of the 3 donor exposures and in-hospital mortality in the 3 cohorts. Hazard ratios for in-hospital mortality per transfused unit from female donors were 0.99 (95% CI, 0.96-1.03) for the KPNC cohort, 1.00 (95% CI, 0.99-1.01) for the REDS-III cohort, and 1.00 (95% CI, 0.99-1.00) for the SCANDAT cohort. For units from previously pregnant or parous female donors, hazard ratios were 1.00 (95% CI, 1.00-1.01) for the KPNC cohort, 1.01 (95% CI, 0.98-1.03) for the REDS-III cohort, and 1.00 (95% CI, 1.00-1.01) for the SCANDAT cohort. For units from sex-discordant transfusions, hazard ratios were 1.02 (95% CI, 0.99-1.05) for the KPNC cohort, 0.99 (95% CI, 0.98-1.00) for the REDS-III cohort, and 1.00 (95% CI, 0.99-1.00) for the SCANDAT cohort. CONCLUSIONS AND RELEVANCE: Among red blood cell transfusion recipients, transfusions from female, previously pregnant, or sex-discordant donors were not significantly associated with increased mortality.
引用
- Edgren G, Murphy EL, Brambilla DJ, et al. Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients. JAMA. 2019. PMID: 31184739. doi:10.1001/jama.2019.7084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。